Publications 2023

Gjølberg TT, Wik JA, Johannessen H, Krüger S, Bassi N, Christopoulos PF, Bern M, Foss S, Petrovski G, Moe MC, Haraldsen G, Fosse JH, Skålhegg BS, Andersen JT, Sundlisæter E (2023)
Antibody blockade of Jagged1 attenuates choroidal neovascularization
Nat Commun, 14 (1), 3109
DOI 10.1038/s41467-023-38563-w, PubMed 37253747

Publications 2021

Christopoulos PF, Gjølberg TT, Krüger S, Haraldsen G, Andersen JT, Sundlisæter E (2021)
Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases
Front Immunol, 12, 668207
DOI 10.3389/fimmu.2021.668207, PubMed 33912195

Publications 2020

Thyssen JP, Heegaard S, Ivert L, Remitz A, Agner T, De Bruin-Weller M, Huldt-Nystrøm T, Korhonen L, Ivert LU, Leinonen P, Mandelin J, Särnhult T, Schopf T, Sundlisæter E, Thomsen SF, Tzellos T, Vestergaard C, von Kobyletzki L, Bradley M (2020)
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process
Acta Derm Venereol, 100 (16), adv00264
DOI 10.2340/00015555-3629, PubMed 32926175

Publications 2018

Poulsen LC, Edelmann RJ, Krüger S, Diéguez-Hurtado R, Shah A, Stav-Noraas TE, Renzi A, Szymanska M, Wang J, Ehling M, Benedito R, Kasprzycka M, Bækkevold E, Sundnes O, Midwood KS, Scott H, Collas P, Siebel CW, Adams RH, Haraldsen G, Sundlisæter E, Hol J (2018)
Inhibition of Endothelial NOTCH1 Signaling Attenuates Inflammation by Reducing Cytokine-Mediated Histone Acetylation at Inflammatory Enhancers
Arterioscler Thromb Vasc Biol, 38 (4), 854-869
DOI 10.1161/ATVBAHA.117.310388, PubMed 29449332

Sundlisæter E, Tvedt C (2018)
Antiangiogenic treatment of ocular diseases
Tidsskr Nor Laegeforen, 138 (18)
DOI 10.4045/tidsskr.17.1083, PubMed 30421732

Publications 2014

Rajcevic U, Knol JC, Piersma S, Bougnaud S, Fack F, Sundlisaeter E, Søndenaa K, Myklebust R, Pham TV, Niclou SP, Jiménez CR (2014)
Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture
Proteome Sci, 12, 39
DOI 10.1186/1477-5956-12-39, PubMed 25075203

Publications 2012

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017

Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, Udalova IA, Midwood KS, Kasprzycka M, Haraldsen G (2012)
The alarmin IL-33 is a notch target in quiescent endothelial cells
Am J Pathol, 181 (3), 1099-111
DOI 10.1016/j.ajpath.2012.06.003, PubMed 22809957

Publications 2009

Sundlisaeter E, Mjåland O (2009)
[Complications after gastrointestinal surgery]
Tidsskr Nor Laegeforen, 129 (20), 2098-102
DOI 10.4045/tidsskr.09.0001, PubMed 19855447

Sundlisaeter E, Røsland GV, Hertel JK, Sakariassen PØ, Almås B, Dicko A, Søndenaa K (2009)
Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa
APMIS, 117 (3), 212-21
DOI 10.1111/j.1600-0463.2008.00025.x, PubMed 19245594

Publications 2007

Sundlisaeter E, Dicko A, Sakariassen PØ, Sondenaa K, Enger PØ, Bjerkvig R (2007)
Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects
Int J Cancer, 121 (7), 1401-9
DOI 10.1002/ijc.22996, PubMed 17640040

Publications 2006

Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ (2006)
Angiogenesis-independent tumor growth mediated by stem-like cancer cells
Proc Natl Acad Sci U S A, 103 (44), 16466-71
DOI 10.1073/pnas.0607668103, PubMed 17056721

Sundlisaeter E, Wang J, Sakariassen PØ, Marie M, Mathisen JR, Karlsen BO, Prestegarden L, Skaftnesmo KO, Bjerkvig R, Enger PØ (2006)
Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation
Neuropathol Appl Neurobiol, 32 (4), 419-27
DOI 10.1111/j.1365-2990.2006.00744.x, PubMed 16866987